Completed Access to Information Requests

Follow:

  • RSS
  • Cite

    Cite

    APA

    Open Government - Government of Canada. (2017, December 10). Completed Access to Information Requests. Retrieved from http://open.canada.ca/en/search/ati?search_api_fulltext=&page=2950
    MLA

    “Completed Access to Information Requests.” Open Government - Government of Canada, 10 December 2017, http://open.canada.ca/en/search/ati?search_api_fulltext=&page=2950
    (Report an issue with citation)
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 61813 record(s)

Req # A-2021-000485

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-118044-520.

Organization: Health Canada

60 page(s)
May 2022

Req # A-2021-000543

Adverse Drug Reactions (ADRs) for ALEMTUZUMAB. Report numbers: E2B_03447489, 000925250, E2B_03388355, E2B_03314391, E2B_03519982, E2B_03388358, E2B_03387885, 000920913, E2B_03508779, E2B_03463306, E2B_03398550.

Organization: Health Canada

218 page(s)
May 2022

Req # A-2021-000702

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-118044-520.

Organization: Health Canada

55 page(s)
May 2022

Req # A-2021-000909

Adverse Drug Reactions (ADRs). Report numbers: E2B_02475445, 000725803, 00072726, E2B_02829775, E2B_02837423, E2B_02879227, 000908839, 000910652, E2B_03369143, E2B_03502675, 000928389.

Organization: Health Canada

193 page(s)
May 2022

Req # A-2021-000920

Adverse Drug Reactions (ADRs). Report numbers: E2B_04118435, E2B_04123365, E2B_04127815, E2B_04123514, E2B_04184408, E2B_04111061, E2B_04178524, E2B_04109172, E2B_04158954, E2B_04181636, E2B_04155996.

Organization: Health Canada

309 page(s)
May 2022

Req # A-2021-001072

Adverse Drug Reactions (ADRs). Report numbers: E2B_03464296, 000938129, E2B_03311833, E2B_03659837, E2B_04064304.

Organization: Health Canada

34 page(s)
May 2022

Req # A-2021-001093

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-112628-914.

Organization: Health Canada

9 page(s)
May 2022

Req # A-2021-001125

Adverse Drug Reactions (ADRs) for INSULIN GLARGINE. Report numbers: E2B_03895786, E2B_03581341, E2B_03868449, E2B_04040159, E2B_03889625, E2B_03572467.

Organization: Health Canada

90 page(s)
May 2022

Req # A-2021-001129

Adverse Drug Reactions (ADRs) for METRONIDAZOLE. Report numbers: 938434, E2B_03598788, E2B_03551852, E2B_03855683, 942803, 948620, 927672, E2B_03978866, E2B_03581497, E2B_03949972, 937385, E2B_03651427, E2B_03679537, E2B_03551750.

Organization: Health Canada

163 page(s)
May 2022

Req # A-2021-001193

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-115231-297.

Organization: Health Canada

47 page(s)
May 2022
Date modified: